| Company Name: |
BOC Sciences |
| Tel: |
16314854226 |
| Email: |
info@bocsci.com |
| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
CB-25 manufacturers
- CB-25
-
- $97.00
-
2026-07-15
- CAS:869376-63-6
- Purity:
- Supply Ability: 10g
|
| Product Name: | CB-25 | | Synonyms: | CB-25;Undecanamide, N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-;N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)undecanamide | | CAS: | 869376-63-6 | | MF: | C25H41NO3 | | MW: | 403.6 | | EINECS: | | | Product Categories: | | | Mol File: | 869376-63-6.mol |  |
| | CB-25 Chemical Properties |
| Melting point | 70.7 °C(Solv: chloroform (67-66-3); methanol (67-56-1)) | | Boiling point | 594.7±30.0 °C(Predicted) | | density | 1.03±0.1 g/cm3(Predicted) | | solubility | DMF: 30 mg/ml; DMSO: 30 mg/ml; Ethanol: 50 mg/ml; Ethanol:PBS (pH 7.2) (1:2): 0.3 mg/ml | | form | A crystalline solid | | pka | 9.75±0.10(Predicted) | | color | White to off-white |
| | CB-25 Usage And Synthesis |
| Description | CB-25 is a stable analog of Δ9-tetrahydrocannabinol (THC) and anandamide (AEA). It exhibits high affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors with Ki values of 5.2 and 13 nM, respectively. CB-25 behaves as an inverse agonist for the CB1 receptor as assessed in a cyclic AMP (cAMP) functional assay. | | Uses | CB-25 is a stable anandamide analog CB1 inverse agonist. | | References | [1] ANTONELLA BRIZZI. Design, Synthesis, and Binding Studies of New Potent Ligands of Cannabinoid Receptors[J]. Journal of Medicinal Chemistry, 2005, 48 23: 7343-7350. DOI: 10.1021/jm0501533
[2] M G CASCIO. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands[J]. British Journal of Pharmacology, 2009, 149 4: 431-440. DOI: 10.1038/sj.bjp.0706888 |
| | CB-25 Preparation Products And Raw materials |
|